Business
InMed Announces Results of 2025 Annual General and Special Meeting
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today confirmed that, at its annual general and special meeting of shareholders held on December 17, 2025 (the "Meeting"), the matters put forward before shareholders for consideration and approval as set out in...
About this update from Inmed Pharmaceuticals Inc.
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today confirmed that, at its annual general and special meeting of shareholders held on December 17, 2025 (the "Meeting"), the matters put forward before shareholders for consideration and approval as set out in InMed's notice of meeting and management information circular, dated November 3, 2025, were voted upon by the shareholders. A total of 993,491 common shares of the Company, representing approximately 35.43% of the Company's 2,804,186 issued and outstanding common shares, were represented in person or by proxy at the Meeting.","length":861,"tagName":"p"},{"type":"text","content":"Results of the vote for the election of the board of directors (the "Board") at the Meeting are set out as follows:","length":125,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"rowspan":"2","style":"vertical-align:bottom;border-bottom:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Director","length":8,"tagName":"p","attribs":{}}]},{"colspan":"2","style":"width:18%;vertical-align:middle;text-align:center;border-bottom:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Votes For","length":9,"tagName":"p","attribs":{}}]},{"colspan":"2","style":"width:18%;vertical-align:middle;text-align:center;border-bottom:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Withheld Votes","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"text-align:center;vertical-align:middle;border-bottom:1px solid #000000;border-left:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Number","length":6,"tagName":"p","attribs":{}}]},{"style":"width:18%;vertical-align:middle;text-align:center;border-bottom:1px solid #000000;border-left:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Percentage","length":10,"tagName":"p","attribs":{}}]},{"style":"width:18%;vertical-align:middle;text-align:center;border-bottom:1px solid #000000;border-left:1px solid #000000;font-size:10px;","val":[{"type":"text","content":"Number","length":6,"tagName"...